BIO International Convention · Jun 2026
BIO lists Delineate as a Y Combinator–backed AI startup focused on accelerating Model-Informed Drug Development.
Agents for Accelerated Clinical Trial Design
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Delineate is a Cambridge-based biopharma software startup that uses custom LLM and computer-vision workflows to extract and structure research literature, patents, figures, and plots into analysis-ready datasets for model-informed drug development and clinical-trial design.
Primary product
AI agents and evidence-synthesis software for biopharma clinical-trial design
Founded
2024
Headquarters
Cambridge, Massachusetts, United States
Team size
11-50 employees
Industry
Software Development
Sub-industry
AI for biopharma evidence synthesis and clinical trial design
Offices
1010 Massachusetts Ave, Cambridge, MA 02138, United States
Open Positions
0 jobs at Delineate
No open positions
Check back later for new openings